A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
PHASE3
The purpose of this study is to evaluate efficacy of erdafitinib versus che...
Status
Active Not Recruiting
Location
Alaska Urological Institute dba Alaska Clinical Research Center
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma
PHASE1
The purpose of this study is to determine recommended Phase 2 dose \[RP2D\]...
Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment Options
N/A
The purpose of this program is to provide participants an early access to e...